1053: Generic Drugs | Skeptical Sunday

1053: Generic Drugs | Skeptical Sunday

01:11:092024-09-22

Jaksokuvaus

Are generic drugs as good as their name-brand counterparts? On Skeptical Sunday, Dave Farina compares their development, prices, and efficacy. Welcome to Skeptical Sunday, a special edition of The Jordan Harbinger Show where Jordan and a guest break down a topic that you may have never thought about, open things up, and debunk common misconceptions. This time around, we’re joined by Is This Wi-Fi Organic?: A Guide to Spotting Misleading Science Online author and host of the Professor Dave Debates podcast, Dave Farina! On This Week's Skeptical Sunday: Generic drugs contain the same active ingredients as brand-name drugs, but are typically much cheaper due to not having to absorb research and development costs. Drug patents typically last around 20 years, giving companies a period of market exclusivity to recoup their investment before generics can be produced. While the active ingredients are identical, there can be minor differences in inactive ingredients (excipients) between brand-name and generic drugs that may slightly affect bioavailability. Regulatory bodies like the FDA play a crucial role in ensuring drug safety and efficacy, though rare oversights can still occur. Consumers can make informed decisions about medications by understanding the similarities between brand-name and generic drugs, consulting with healthcare providers, and staying aware of drug safety information from reliable sources. This knowledge empowers individuals to potentially save money on prescriptions while still receiving effective treatment. Connect with Jordan on Twitter, Instagram, and YouTube. If you have something you'd like us to tackle here on Skeptical Sunday, drop Jordan a line at jordan@jordanharbinger.com and let him know! Connect with Dave Farina on YouTube, Twitter, and Instagram, and check out the Professor Dave Debates podcast here or wherever you enjoy listening to fine podcasts. Dave’s book, Is...

Tutustu

Lisää

  • Evästekäytäntö
  • Käyttöehdot
  • Tietosuojakäytäntöexternal link
  • Medialleexternal link
logo

© Podme AB 2024